enVVeno Medical (NVNO) Change in Accured Expenses (2017 - 2026)
enVVeno Medical (NVNO) posted quarterly Change in Accured Expenses of -$262000.0 for Q2 2026, down 119.45% year-over-year from $1.3 million in Q2 2025, and down 1846.67% quarter-over-quarter from $15000.0 in Q1 2026.
enVVeno Medical (NVNO) Change in Accured Expenses (2017 - 2026) Analysis & Trends
enVVeno Medical's Change in Accured Expenses history runs 10 years deep, the most recent figure standing at -$262000.0 for Q2 2026.
- In Q2 2026, Change in Accured Expenses fell 119.45% year-over-year to -$262000.0; the TTM figure through Jun 2026 stood at -$1.2 million (down 189.1% YoY), while the FY2025 annual figure was $1000.0, down 99.86% from the prior year.
- Change in Accured Expenses for Q2 2026 stood at -$262000.0, down from $15000.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $1.3 million in Q2 2025, with the low at -$667000.0 in Q4 2023.
- The 5-year median for Change in Accured Expenses is -$14000.0 (2022), against an average of $6000.0.
- Peak annual rise in Change in Accured Expenses reached 1590.7% in 2023, while the deepest fall reached 605.3% in 2023.
- enVVeno Medical's Change in Accured Expenses stood at $132000.0 in 2022, then tumbled by 605.3% to -$667000.0 in 2023, then surged by 78.86% to -$141000.0 in 2024, then tumbled by 170.92% to -$382000.0 in 2025, then soared by 31.41% to -$262000.0 in 2026.
- Business Quant data shows NVNO's Change in Accured Expenses at -$262000.0 in Q2 2026, $15000.0 in Q1 2026, and -$382000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 4.80 Mn |
| 10 | enVVeno Medical | 7.12 Mn | 7.12 Mn | - | -262,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -262,000.00 |
| Jun 30, 2026 | -262,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Dec 31, 2025 | -382,000.00 |
| Dec 31, 2025 | -382,000.00 |
| Sep 30, 2025 | -524,000.00 |
| Sep 30, 2025 | -524,000.00 |
| Jun 30, 2025 | 1.35 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | -440,000.00 |
| Mar 31, 2025 | -440,000.00 |
| Dec 31, 2024 | -141,000.00 |
| Dec 31, 2024 | -141,000.00 |
| Sep 30, 2024 | 528,000.00 |
| Sep 30, 2024 | 528,000.00 |
| Jun 30, 2024 | 201,000.00 |
| Jun 30, 2024 | 201,000.00 |
| Mar 31, 2024 | 110,000.00 |
| Mar 31, 2024 | 110,000.00 |